AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Medical Devices, Pharma & Biotech BS: Gilead Sciences (ZYDELIG) (zydelig.com)
This is a benchmark for low-BS medical communication. It prioritizes clinical transparency and regulatory safety requirements over marketing narrative. The presence of specific, cited percentages and months of survival data provides absolute substance.
Consolidate the duplicate H2 ‘What is ZYDELIG?’ on the homepage to improve heading hierarchy. Provide direct outbound links to the peer-reviewed publications cited in the footnotes to facilitate faster clinician verification. Update the patient resources section to include the original publication dates of the external advocacy tips to ensure temporal relevance.
Information density is exceptionally high for a public-facing website. The About ZYDELIG page provides specific clinical metrics, including a 19.4-month progression-free survival rate versus a 6.5-month control and an 84 percent response rate. This substance-to-fluff ratio is far superior to typical corporate marketing sites, with marketing language largely confined to standard navigation labels.
Parameter drift, trailing slash inconsistencies, and language leaks create unintended alternate identities. Get a Clinical Canonical Diagnosis to reveal where duplicate embeddings are silently created.
Semantic drift is nearly zero. The homepage H1 ‘support your journey’ is a standard patient-centric entry point, but it immediately aligns with technical dosing and side-effect management on sub-pages. There is no disconnect between the patient-friendly introduction and the specific clinical data delivered in the About Zydelig and HCP sections.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
The site avoids trust theatre entirely. It has a review_count of 0 and relies instead on high-quality external validation, including FDA-regulated prescribing information and ClinicalTrials.gov study parameters. It prominently features mandatory boxed warnings for fatal toxicities, which represents the highest form of regulatory substance over marketing bullshit.
Proof density is very high across the analyzed pages. Almost every therapeutic claim is superscripted with a citation (1-5) referencing specific clinical studies. The side-effects management page even includes specific percentages (67 percent) regarding the success of dose modifications in clinical trials.
To see how the methodology translates into real diagnostic output, review a full executive level analysis applied to a global fashion retailer. View the Mango Executive SEO Strategy for a concrete example of how structural gaps, semantic weaknesses, and conversion friction are surfaced in practice.
While the site uses standard pharma fingerprints like ‘Patient Resources’ and ‘For Healthcare Professionals,’ it fills these templates with granular substance. The clinical data provided (e.g., specific 66 percent disease-free progression at 1 year) is unique to the product and cannot be copy-pasted onto a competitor’s drug.
There are no authority gaps. The site is explicitly branded by Gilead and cites the U.S. Food and Drug Administration (FDA) as the recognizing authority in the schema_json. It correctly uses MedicalWebPage schema to define its audience (Patient and Clinician) and specialty (Oncologic), matching its content perfectly.
There is no disconnect between claims and evidence. Performance claims like ‘Proven effective in relapsed CLL’ are immediately followed by clinical trial parameters (n=220) and specific statistical outcomes. This is a data-led technical communication that satisfies even the strictest forensic proof requirements.
Medical Devices, Pharma & Biotech BS: Gilead Sciences (ZYDELIG) (zydelig.com)
The site perfectly matches the Pharma & Biotech category, functioning as a regulated product information portal. It contains mandatory safety disclosures, FDA-regulated indications, and clinical trial results characteristic of a prescription drug website.
Before embeddings, before entities, before retrieval — the crawler must reach the text. Open the Crawlability & Indexation Guide to learn how access failures erase meaning long before interpretation begins.
“The extremely low score of 11 is driven by high Information Density and nearly perfect Semantic Coherence. The site relies entirely on verifiable clinical data rather than trust theatre, and its technical schema is robustly implemented with zero identity gaps.”